News2021-07-23T23:29:34+00:00

News

7th Annual CAR-TCR Summit to Feature Presentation By Exacis Biotherapeutics CEO

September 18th, 2022|

Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will present “Leveraging mRNA Based Gene Editing to Optimize Advancement of Safe and Cost-Effective IPSC Products” as part of the focus track on Innovations in Gene Engineering and Editing at the 7th Annual CAR-TCR Summit in Boston on September 19, 2022.

Go to Top